Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone +/- Cetuximab in TNBC
NCT00633464Phase 2Completed
- Sponsor
- R-Pharm
- Start
- Jun 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of ixabepilone in triple negative breast cancer (TNBC), sponsored by R-Pharm. Started Jun 2008; status: completed.
02
Drugs
ixabepilone
03
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT00633464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00633464.